Family Medicine Commons^™

Availability Of Pain Medications For Npo Patients, Anna Augustin Do, Kyle Borodunovich Do, Sean Quinonez Do, Furqan Haq, My Myers Md

Family Medicine

In recent years, the opioid epidemic has been a key catalyst in changing the medical standards for treating both acute and chronic pain. Instead of relying heavily on narcotics for pain management, practitioners are not encouraged to adapt a non-pharmacologic, non-opioid approach to analgesia. While many guidelines have been set to standardize outpatient pain management, the rules surrounding inpatient analgesia are limited or lacking.

A Cost-Benefit Analysis Of Choosing Non-Instrumental Bedside Screenings In Patients With Low Risk Factors For Ped Not Meeting The Cms Criteria Of Pmv (Prolonged Mechanical Ventilation), Kyle Barjon Do, Giselle Falconi, Bharat Upadhyay Md

Family Medicine

No abstract provided.

A Comparison Of Opioid Abuse Screening Tools Of Detection Of High Risk Patients In The Inpatient Setting, Grace Gu Md, Albert Cheng Md, Darren Rahaman Md, Shyh-Jeun Wang Md, Maureen Strohm Md, Napatkamon Ayutyanont

Family Medicine

• The United States is currently experiencing an opioid epidemic, which claims 115 lives daily by overdose.
• Tools for identifying patients at increased risk for abuse include: Screener and Opioid Assessment for Patients with Pain (SOAPP-R) and Opioid Risk Tool (ORT).
• However, data is lacking for the comparison of the two most commonly used opioid screen tools (SOAPP-R and ORT).
• We are comparing the effectiveness of these screening tools for patients being discharged from the hospital who have no "red flags" for abuse.

Relationship Of Patient Self-Administered Copd Assessment Test To Physician Standard Assessment Of Chronic Obstructive Pulmonary Disease In A Family Medicine Residency Training Program, Jessica E. Burchette, Ivy A. Click, Leigh Johnson, S. Alicia Williams, Brett Tyler Morgan

Journal of Patient-Centered Research and Reviews

Assessing the global impact of chronic obstructive pulmonary disease (COPD) on a patient’s life can be difficult to perform in the clinical setting due to time constraints and workflow challenges. The primary objective of this study was to compare disease impact ratings between patient self-administered COPD Assessment Test (CAT) and physician standard office assessment. This prospective study was conducted at a family medicine residency clinic in northeast Tennessee. The study included two study groups: 1) adult patients seen at the clinic during the 3-month study period with an active diagnosis of COPD, and 2) their physicians. Physicians’ assessment of the …